Editing Philips (section)

===North America===
====Canada====
[[File:PhilipsMarkham.jpg|thumb|Philips headquarters in Markham, February 2020]]
Philips Canada was founded in 1941 when it acquired Small Electric Motors Limited. It is well known in medical systems for diagnosis and therapy, lighting technologies, shavers, and consumer electronics. The Canadian headquarters are located in [[Markham, Ontario]].

For several years, Philips manufactured lighting products in two Canadian factories. The [[London, Ontario]], plant opened in 1971. It produced A19 lamps (including the "Royale" long life bulbs), [[Parabolic aluminized reflector light|PAR38]] lamps and T19 lamps (originally a [[Westinghouse Electric (1886)|Westinghouse]] lamp shape). Philips closed the factory in May 2003. The [[Trois-Rivières]], Quebec, plant was a Westinghouse facility which Philips continued to run it after buying Westinghouse's lamp division in 1983. Philips closed this factory a few years later, in the late 1980s.

====Mexico====
Philips Mexico Commercial SA de CV is headquartered in Mexico City. This entity was incorporated in FY{{nbsp}}2016 to sales consumer lifestyle and healthcare portfolios in the market.

====United States====
[[File:PhilipsNAHQ.jpg|thumb|right|upright=0.9|Previous Philips' North American headquarters in [[Andover, Massachusetts]], June 2009]]
Philips' Electronics North American headquarters is in [[Cambridge, Massachusetts]].<ref>{{cite news|url=https://www.bostonglobe.com/business/2018/01/11/dutch-firm-philips-move-north-american-headquarters-from-andover-cambridge/aP8HXyXlQFaIvGufY9tI7M/story.html|title=Dutch firm Philips to move North American headquarters from Andover to Cambridge|newspaper=[[The Boston Globe]]|access-date=7 April 2018|archive-url=https://web.archive.org/web/20180418014044/http://www.bostonglobe.com/business/2018/01/11/dutch-firm-philips-move-north-american-headquarters-from-andover-cambridge/aP8HXyXlQFaIvGufY9tI7M/story.html|archive-date=18 April 2018|url-status=live}}</ref> Philips Lighting has its corporate office in [[Somerset, New Jersey]]; with manufacturing plants in [[Danville, Kentucky]]; [[Salina, Kansas]]; [[Dallas]] and [[Paris, Texas]]; and distribution centers in [[Mountain Top, Pennsylvania]]; [[El Paso, Texas]]; [[Ontario, California]]; and [[Memphis, Tennessee]]. Philips Healthcare is headquartered in Cambridge, Massachusetts, and operates a health-tech hub in [[Nashville, Tennessee|Nashville]] with over 1,000 jobs. The North American sales organization is based in [[Bothell, Washington]]. There are also manufacturing facilities in Bothell, Washington; [[Baltimore, Maryland]]; [[Cleveland, Ohio]]; [[Foster City, California]]; [[Gainesville, Florida]]; [[Milpitas, California]]; and [[Reedsville, Pennsylvania]]. Philips Healthcare formerly had a factory in [[Knoxville, Tennessee]]. Philips Consumer Lifestyle has its corporate office in [[Stamford, Connecticut]].  Philips Lighting has a Color Kinetics office in [[Burlington, Massachusetts]]. Philips Research North American headquarters is in Cambridge.

In 2007, Philips entered into a definitive merger agreement with North American luminaires company Genlyte Group Incorporated, which provides the company with a leading position in the North American [[luminaire]]s (also known as "[[lighting fixture]]s"), controls and related products for a wide variety of applications, including [[solid state lighting]]. The company also acquired Respironics, which was a significant gain for its healthcare sector. On 21 February 2008, Philips completed the acquisition of Baltimore-based VISICU. VISICU was the creator of the [[eICU]] concept of the use of Telemedicine from a centralized facility to monitor and care for ICU patients.

In April 2020, the [[United States Department of Health & Human Services]] (HHS) entered into a contract with Philips Respironics for 43,000 bundled Trilogy Evo Universal ventilator (EV300) hospital ventilators.<ref>{{cite web| title = Trilogy EV300 Hospital ventilator| work = Philips Healthcare| access-date = 3 September 2020| url = https://www.usa.philips.com/healthcare/product/HCDS2200X11B/trilogy-ev300-hospital-ventilator| archive-date = 15 February 2022| archive-url = https://web.archive.org/web/20220215141706/https://www.usa.philips.com/healthcare/product/HCDS2200X11B/trilogy-ev300-hospital-ventilator| url-status = live}}</ref> This included the production and delivery of ventilators to the [[Strategic National Stockpile]]—about  156,000 by the end of August 2020 and 187,000 more by the end of 2020.<ref name="Philips_20200831">{{cite web| title = Philips EV300 ventilator supply contract with U.S. Department of Health and Human Services to end after delivery of 12,300 bundled ventilator configurations| work = Philips| date = 31 August 2020| access-date = 3 September 2020| url = https://www.philips.com/a-w/about/news/archive/standard/news/press/2020/20200831-philips-ev300-ventilator-supply-contract-with-us-department-of-health-and-human-services-to-end-after-delivery-of-12300-bundled-ventilator-configurations.html| archive-date = 1 October 2022| archive-url = https://web.archive.org/web/20221001052709/https://www.philips.com/a-w/about/news/archive/standard/news/press/2020/20200831-philips-ev300-ventilator-supply-contract-with-us-department-of-health-and-human-services-to-end-after-delivery-of-12300-bundled-ventilator-configurations.html| url-status = live}}</ref> During the [[COVID-19 pandemic]], beginning in March 2020, in response to an international demand, Philips increased production of the ventilators fourfold within five months. Production lines were added in the United States with employees working around the clock in factories producing ventilators, in Western Pennsylvania and California, for example.<ref name="Philips_20200831"/>

In March 2020, [[ProPublica]] published a series of articles on the Philips ventilator contract as negotiated by trade adviser [[Peter Navarro]]. In response to the ProPublica series, in August, the [[United States House of Representatives]] undertook a "congressional investigation" into the acquisition of the Philips ventilators. The lawmakers investigation found "evidence of fraud, waste and abuse".<ref name="ProPublica_Philips_Callahan_20200901">{{Cite news| title = The Trump Administration Is Backing Out of a $647 Million Ventilator Deal After ProPublica Investigated the Price| first1 = Patricia| last1 = Callahan| author-link=Patricia Callahan |first2 = Sebastian| last2 = Rotella| author2-link=Sebastian Rotella |date = 1 September 2020| work = ProPublica| access-date = 3 September 2020| url = https://www.propublica.org/article/the-trump-administration-is-backing-out-of-a-647-million-ventilator-deal-after-propublica-investigated-the-price| archive-date = 4 January 2021| archive-url = https://web.archive.org/web/20210104064108/https://www.propublica.org/article/the-trump-administration-is-backing-out-of-a-647-million-ventilator-deal-after-propublica-investigated-the-price| url-status = live}}</ref>—the deal negotiated by Navarro had resulted in an over-payment to Philips by the US government of "hundreds of millions".<ref name="ProPublica_Philips_Callahan_20200901"/>